Dr. Rajesh Shinghal, MD

Dr. Shinghal practices at Palo Alto Medical Foundation-Fremont Center in Fremont, California.

Dr. Shinghal's NPI, 1225133788, was assigned on September 13, 2006. Dr. Shinghal graduated from Stanford University School Of Medicine in 1996. Dr. Shinghal holds California license A63122.

Dr. Shinghal's primary practice is Palo Alto Medical Foundation-Fremont Center, at 3200 Kearney Street, Fremont, CA 94538. The practice phone is (510) 498-2812.

Dr. Shinghal's primary practice is Palo Alto Medical Foundation-Fremont Center in Fremont, California. Dr. Shinghal is also affiliated with Washington Health. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Shinghal to 4 more hospitals, each named with a free account. Dr. Shinghal's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shinghal practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Shinghal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Shinghal is board certified in urology by the American Board of Urology. Dr. Shinghal is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Shinghal treats.

CMS data shows 2,848 Medicare services from Dr. Shinghal across 20 procedure codes in 2024, for 673 Medicare patients. Medicare paid $201,653 for them.

CMS counts 673 Medicare patients who saw Dr. Shinghal in 2024. The largest group is 65 to 74, with 291 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shinghal's median patient age at 57, with 24% women.

In 2024, Dr. Shinghal wrote 3,269 Medicare Part D claims for 772 patients. 93% of them were for generic drugs. CMS names the drug for 3,105 of them, across 33 drugs with 11 or more claims each, at $237,626 in total drug cost. In 2023, CMS named 2,723 claims across 36 drugs.

Dr. Shinghal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shinghal as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Shinghal, more than 69% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Shinghal, published from 2008 to 2018. 2008 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Biopsy, Needle and Prostate. Dr. Shinghal has published most often in J Urol. Dr. Shinghal's most frequent co-authors are Tin Chan Ngo, MD, Christopher S. Elliott, MD and James D. Brooks, MD.

CMS Open Payments shows 126 general payments to Dr. Shinghal from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Teleflex LLC paid the most, $49,715. It also lists 1 research payment totaling $280 in 2020.

Dr. Shinghal graduated from Stanford University School Of Medicine in 1996. Dr. Shinghal is a member of AUA and Western Section American Urological Association.

Dr. Shinghal is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.